Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 69 Rectal Neoplasms 10 Triple Negative Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 6 Carcinoma, Intraductal, Noninfiltrating 6 Adenocarcinoma of Lung 6 Breast Carcinoma In Situ 4 Pancreatic Neoplasms 2 Unilateral Breast Neoplasms 1 Transsexualism 1 Solitary Pulmonary Nodule 1 Social Isolation 1 Recurrence 1 Piebaldism 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplastic Cells, Circulating 1 Neoplasm Micrometastasis 1 Margins of Excision 1 Lymphedema 1 Local Recurrence of Malignant Tumor of Breast 1 Inflammatory Breast Neoplasms 1 Gynecomastia 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms 1 Chordoma 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1

Interventions

Cyclophosphamide 38 Paclitaxel 22 Epirubicin 21 Trastuzumab 20 Docetaxel 20 Doxorubicin 19 Carboplatin 15 Radiotherapy 13 Taxes 11 Filgrastim 11 Neoadjuvant Therapy 9 Bevacizumab 9 Fluorouracil 8 pembrolizumab 7 Tamoxifen 7 Albumin-Bound Paclitaxel 7 Capecitabine 6 pertuzumab 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Lapatinib 5 130-nm albumin-bound paclitaxel 5 pegfilgrastim 4 Granulocyte Colony-Stimulating Factor 4 Cisplatin 4 Chemotherapy, Adjuvant 4 Biopsy 4 tipifarnib 3 eribulin 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × Mastectomy, Segmental × Clear all

NCT06131632 2024-01-23

ConSIBreC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Not yet recruiting

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡